Efflux properties of basolateral peptide transporter in human intestinal cell line Caco-2

被引:35
|
作者
Irie, M [1 ]
Terada, T [1 ]
Okuda, M [1 ]
Inui, K [1 ]
机构
[1] Kyoto Univ, Fac Med, Dept Pharm, Sakyo Ku, Kyoto 6068507, Japan
来源
关键词
peptide transporter; basolateral membrane; intestine; absorption; substrate affinity; simulation;
D O I
10.1007/s00424-004-1326-x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Small peptides and some pharmacologically active compounds are absorbed from the small intestine by the apical H+-coupled peptide transporter 1 (PEPT1) and the basolateral peptide transporter. Here we investigated the efflux properties of the basolateral peptide transporter in Caco-2 cells using two strategies, efflux measurements and a kinetic analysis of transepithelial transport of glycylsarcosine (Gly-Sar). [C-14]Gly-Sar efflux through the basolateral membrane was not affected significantly by the external pH. Both approaches revealed that the basolateral peptide transporter was saturable in the efflux direction, and that the affinity was lower than that in the influx direction. For two peptide-like drugs, there was no difference in substrate recognition by the basolateral peptide transporter between the two sides of the membrane. Using the kinetic parameters of PEPT1 and the basolateral peptide transporter, a computational model of Gly-Sar transport in Caco-2 cells was constructed. The simulation fitted the experimental data well. Our findings suggested that substrate affinity of the basolateral peptide transporter is apparently asymmetric, but pH-dependence and substrate specificity are symmetric for the two directions of transport. The behaviour of Gly-Sar in Caco-2 cells could be predicted by a mathematical model describing the peptide transporters.
引用
收藏
页码:186 / 194
页数:9
相关论文
共 50 条
  • [31] Copper uptake and intracellular distribution in the human intestinal Caco-2 cell line
    Simonetta Ferruzza
    Yula Sambuy
    Maria Rosa Ciriolo
    Angelo De Martino
    Paolo Santaroni
    Giuseppe Rotilio
    Maria-Laura Scarino
    Biometals, 2000, 13 : 179 - 185
  • [32] UPTAKE AND TRANSPORT CHARACTERISTICS OF GABAPENTIN IN HUMAN INTESTINAL CELL LINE CACO-2
    Naoki, Shiota
    Nakanishi, Kengo
    Wada, Miyuki
    Fujita, Takuya
    DRUG METABOLISM REVIEWS, 2007, 39 : 288 - 289
  • [33] Preliminary study of thalidomide transport by the human intestinal cell line Caco-2
    Zhou, SF
    Li, Y
    Kestell, P
    Paxton, JW
    DRUG METABOLISM REVIEWS, 2002, 34 : 148 - 148
  • [34] Effects of Peptide Structure on Transport Properties of Seven Thyrotropin Releasing Hormone (TRH) Analogues in a Human Intestinal Cell Line (Caco-2)
    Ute Werner
    Thomas Kissel
    Werner Stüber
    Pharmaceutical Research, 1997, 14 : 246 - 250
  • [35] Effects of peptide structure on transport properties of seven thyrotropin releasing hormone (TRH) analogues in a human intestinal cell line (Caco-2)
    Werner, U
    Kissel, T
    Stuber, W
    PHARMACEUTICAL RESEARCH, 1997, 14 (02) : 246 - 250
  • [36] CEPHALEXIN SHARES A TRANSPORTER WITH DIPEPTIDES AND PARA-AMINOHIPPURIC ACID IN THE HUMAN INTESTINAL-CELL LINE, CACO-2
    BERGIN, L
    DANTZIG, AH
    FASEB JOURNAL, 1988, 2 (04): : A752 - A752
  • [37] Investigation of the intestinal absorption of immunosuppressive drugs using the human intestinal Caco-2 cell line
    Boussera, B.
    Picard, N.
    Liagre, B.
    Beneytout, J. L.
    Marquet, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 45 - 45
  • [38] A HUMAN INTESTINAL-CELL LINE, CACO-2 - A MODEL FOR STUDYING BIOTIN INTESTINAL UPTAKE
    SAID, HM
    MA, TY
    DYER, D
    GASTROENTEROLOGY, 1993, 104 (04) : A277 - A277
  • [39] Na+-dependent dipeptide uptake at the basolateral membrane of human intestinal Caco-2 cell monolayers
    Henderson, FD
    Kennedy, DJ
    Ayrton, A
    Simmons, NL
    Thwaites, DT
    JOURNAL OF PHYSIOLOGY-LONDON, 2002, 539 : 21P - 22P
  • [40] σ receptor ligand-induced up-regulation of the H+/peptide transporter PEPT1 in the human intestinal cell line Caco-2
    Fujita, T
    Majikawa, Y
    Umehisa, S
    Okada, N
    Yamamoto, A
    Ganapathy, V
    Leibach, FH
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 242 - 246